FDA Inspection 835676 — Grifols Biomat

Grifols Biomat — FEI 3002717772

The FDA completed an inspection of Grifols Biomat on June 5, 2013 in Reading, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Reading, PA (United States)